机译:利用夹层节点选择评估,改善Neoadjuvant治疗后Neoadjuvant治疗后的腋生评估:靶向腋窝解剖的实施
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
机译:选择性淋巴结清扫术对淋巴结阳性乳腺癌患者新辅助治疗后的腋窝评估得到改善:靶向腋窝淋巴结清扫术的实现
机译:用Neoadjuvant治疗(Ilina试验)治疗的节点阳性乳腺癌患者腋下超声引导切除患者(ilina试验)新工具,以引导新辅助治疗后剪切节点的切除
机译:节点阳性乳腺癌患者腋窝疏松疏散程度和发病率最小化:基于乳腺淋巴细胞的腋窝淋巴结解剖的实施
机译:乳腺MRI辐射射清,用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
机译:增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
机译:选择性淋巴结清扫术对淋巴结阳性乳腺癌患者新辅助治疗后的腋窝评估得到改善:靶向腋窝淋巴结清扫术的实施
机译:Neoadjuvant化疗(NACT)对节点阳性乳腺癌(NACT)后标记淋巴结活检(MLNB)和靶向腋窝扫描(TAD)的演变作用:系统评价和汇总分析